Logo

Celemics CRV Panel

Dec 14, 2020

Celemics has launched its CRV Panel, a multiplexed, target enrichment panel for next-generation sequencing-based identification of common human respiratory viruses, including SARS-CoV-2. The research-use-only assay detects a total of 39 strains of nine viruses including coronaviruses, rhinoviruses, influenzas, and respiratory syncytial viruses. The panel is bundled with non-cloud-based bioinformatics software that enables a complete workflow. The product is available in the US, Europe, Latin America, the Middle East, Singapore, Malaysia, and Thailand via Celemics' certified retailers.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.